Privacy AI
Regulatory

Health data compliance, handled.

Tell us what you need. We'll tell you what it takes and how long, before you commit.

Contact us

Summary

Contact us
On November 1st, the United Kingdom (UK) published the Bletchley Declaration on the opening day of the Artificial Intelligence (AI) Safety Summit hosted at Bletchley Park, central England.This declaration, made by the UK and joined by 28 countries and international organizations, aims to promote cooperation among them regarding AI.

‍

Why Bletchley ? It was at Bletchley Park that the Enigma code was successfully deciphered during WW2 …

International efforts are being made to examine and address the potential impact of AI systems, especially on principles such as the protection of human rights, data protection, and ethics.👉🏻 The primary focus of this declaration is on Frontier AI. These AI are defined as highly capable general-purpose AI models and specific narrow AI that could exhibit capabilities causing harm

The core concerns of the organizations revolve around the risks posed by Frontier AI, particularly in the domains of cybersecurity and biotechnology. Through international cooperation, they aim to deepen their understanding of these risks and identify actions to address them.

A regulatory approach will be considered by the participating organizations. This includes making, where appropriate, classifications and categorizations of risk based on national circumstances and applicable legal frameworks. International codes of conduct may result from this cooperation.

All AI actors are affected by this Declaration. Actors who develop Frontier AI have a significant responsibility to ensure the safety of these systems. The organizations encourage these actors to provide context-appropriate transparency and accountability in their plans to measure, monitor, and mitigate potentially harmful capabilities and associated effects, particularly to prevent misuse and issues of control, as well as the amplification of other risks.

‍

Click here to read more

Contact us

FAQs

Our frequently questions

No items found.

Find out how iliomad can help your company.

[Map placeholder]
Only visible in production
38.709099
-39.182035
1.6
6d17042a3425c5b3
Your message has been received!
We'll get back to you as soon as possible.
Something went wrong, please try again.
Home

Discover our latest articles

View All Blog Posts
Abstract digital network connecting hospital icons, AI circuit patterns and GDPR shield symbols on a dark blue background, representing healthcare data protection themes
October 28, 2026
Healthtech
Data Breach & Cybersecurity
GDPR
Regulation
LLMS

Healthcare AI Agents, Vendor Breaches and GDPR Reforms: Weekly Privacy and Regulation Digest

This week's digest covers autonomous AI agent risks, a wave of US healthcare vendor breaches, the EU Digital Omnibus GDPR mandate and Swiss voice-biometric enforcement.

Clinical study protocol open on a desk beside a GDPR compliance checklist and a stethoscope, representing data protection obligations in clinical research
October 26, 2026
GDPR
DPIA
Health Data Strategy
Regulations & Guidelines
Regulation

Clinical study protocol data protection: a practical guide for sponsors

Learn how to embed GDPR-compliant data protection into your clinical study protocol. Practical guidance on Section 13, DPIAs, transfers and local formalities.

A researcher reviews a clinical site agreement alongside export control documentation for cross-border data transfer compliance
October 23, 2026
Regulations & Guidelines
Clinical Trials
Regulation
Consent Forms
Big Data

Clinical Site Agreement: Navigating US Export Control Review of Cross-Border Data Transfers in Clinical Trials

Learn how institutional export control policies at clinical sites affect cross-border data transfers in trials, even below DOJ Bulk Data Rule thresholds.